×
Personalis Total Liabilities 2018-2024 | PSNL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Personalis total liabilities from 2018 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
View More
Personalis Total Liabilities 2018-2024 | PSNL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Personalis total liabilities from 2018 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$19.4B
Dr Reddy's Laboratories (RDY)
$11.2B
BridgeBio Pharma (BBIO)
$6.9B
Bausch Health Cos (BHC)
$2.4B
Supernus Pharmaceuticals (SUPN)
$1.9B
Amphastar Pharmaceuticals (AMPH)
$1.5B
Taysha Gene Therapies (TSHA)
$336M
Assembly Biosciences (ASMB)
$81M
Sol-Gel Technologies (SLGL)
$16M
Evoke Pharma (EVOK)
$8M
Teligent (TLGT)
$0M